Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...

Urea prices up 26% compared to early December 2024; Revenues for 2024 at $2.01 billion and adjusted EBITDA at $648 million ...

Fertiglobe reported adjusted EBITDA of $648 million in 2024 and $158 million in Q4 2024, respectively, while adjusted net ...